| 股票代码 | 603259 | 当期评分 | ||||
| 股票名称 | 药明康德 | |||||
| 报告日期 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | -- | -- | 1.4084 | 1.7661 | 0.9918 | ✘ |
| 销售净利润率(%) | 18.3281 | 16.699 | 24.2746 | 14.8491 | 20.2044 | ✔ |
| 销售毛利率(%) | 40.5115 | 41.5021 | 39.154 | 38.7327 | 37.3813 | ✔ |
| 净资产收益率(%) | 17.51 | 19.35 | 12.78 | 10.71 | 7.43 | ✘ |
| 营业增长率(%) | 25.2446 | 26.9636 | 23.8038 | 33.8946 | 27.3351 | ✔ |
| 净利润增长率(%) | 63.9382 | 15.6781 | 79.9679 | -18.0947 | 31.2733 | ✔ |
| 每股收益(%) | 1.08 | 1.31 | 2.23 | 1.14 | 1.03 | ✔ |
| 现金流量比率(%) | 41.815 | 38.8276 | 43.6045 | 43.9533 | 32.9387 | ✔ |
| 三项费用比重(%) | 18.8654 | 22.4758 | 15.8617 | 15.1089 | 17.2811 | ✔ |
| 每股净资产(¥) | 5.9386 | 6.76 | 15.1862 | 10.4851 | 13.0614 | ✔ |
| 流动比率(%) | 1.4377 | 1.1834 | 3.1383 | 1.9087 | 3.2628 | ✔ |
| 速动比率(%) | 1.316 | 1.0261 | 2.8852 | 1.6461 | 2.9415 | ✔ |
| 现金比率(%) | 59.9744 | 53.5216 | 153.1238 | 78.7901 | 78.7901 | ✔ |
| 总资产利润率(%) | 11.0565 | 11.1926 | 13.2416 | 7.3648 | 6.4732 | ✔ |
| 主营利润比重% | 179.2636 | 202.3548 | 145.8504 | 213.3427 | 163.086 | ✔ |
| 应收账款(万元) | 137,416.77 | 159,683.26 | 199,468.84 | 293,654.31 | 360,949.90 | ✔ |
| 应收票据(万元) | 579.58 | 32.48 | 270.85 | 2,473.47 | 356.40 | ✔ |
| 预付款项(万元) | 3,903.34 | 5,192.27 | 7,827.93 | 9,215.81 | 17,083.01 | ✔ |
| 存货(万元) | 51,127.11 | 72,693.77 | 95,247.34 | 174,248.55 | 236,208.00 | ✘ |
| 在建工程(万元) | 71,221.98 | 84,366.53 | 152,698.34 | 209,166.71 | 253,577.58 | ✘ |
| 应付款项(万元) | 30,933.92 | 33,323.79 | 37,936.14 | 57,309.79 | 82,393.14 | ✘ |
| 长期借款(万元) | -- | 30,000.00 | 1,500.00 | 76,240.00 | -- | ✔ |
| 未分配利润(万元) | 101,040.40 | 221,591.87 | 468,784.56 | 577,684.08 | 758,876.76 | ✔ |
| 商誉(万元) | 32,628.62 | 95,803.79 | 114,407.59 | 136,217.62 | 145,587.36 | ✔ |
| 流动资产(万元) | 455,037.35 | 711,364.61 | 1,086,060.08 | 1,657,610.05 | 2,052,426.10 | ✘ |
| 流动负债(万元) | 420,134.52 | 461,942.33 | 376,205.77 | 663,438.64 | 735,276.76 | ✘ |
药明康德603259评分结果 | 69.70分 | 买入/增持 | ||||